Published on: September 10, 2019 at 09:30PM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: semaglutide
Sponsor:   Novo Nordisk A/S
Not yet recruiting
https://ift.tt/2A4Z1ah

0 Comments